Dolutegravir-d6 is an isotopic analog of Dolutegravir which is a second generation HIV-1 integrase strand transfer inhibitor. Dolutegravir is currently in Phase III clinical trials for the treatment of HIV infection. Dolutegravir has been shown to potent
Molecular Weight:
425.42
CAS Number:
[1407166-95-3]
* VAT and and shipping costs not included. Errors and price changes excepted